These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
337 related articles for article (PubMed ID: 21204731)
1. Targeting NR4A1 (TR3) in cancer cells and tumors. Lee SO; Li X; Khan S; Safe S Expert Opin Ther Targets; 2011 Feb; 15(2):195-206. PubMed ID: 21204731 [TBL] [Abstract][Full Text] [Related]
2. Nuclear receptor 4A1 (NR4A1) as a drug target for treating rhabdomyosarcoma (RMS). Lacey A; Hedrick E; Li X; Patel K; Doddapaneni R; Singh M; Safe S Oncotarget; 2016 May; 7(21):31257-69. PubMed ID: 27144436 [TBL] [Abstract][Full Text] [Related]
3. Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists. Hedrick E; Li X; Cheng Y; Lacey A; Mohankumar K; Zarei M; Safe S Breast Cancer Res Treat; 2019 Aug; 177(1):29-40. PubMed ID: 31119568 [TBL] [Abstract][Full Text] [Related]
4. The nuclear orphan receptor NR4A1 regulates β1-integrin expression in pancreatic and colon cancer cells and can be targeted by NR4A1 antagonists. Hedrick E; Lee SO; Safe S Mol Carcinog; 2017 Sep; 56(9):2066-2075. PubMed ID: 28418095 [TBL] [Abstract][Full Text] [Related]
5. Diindolylmethane analogs bind NR4A1 and are NR4A1 antagonists in colon cancer cells. Lee SO; Li X; Hedrick E; Jin UH; Tjalkens RB; Backos DS; Li L; Zhang Y; Wu Q; Safe S Mol Endocrinol; 2014 Oct; 28(10):1729-39. PubMed ID: 25099012 [TBL] [Abstract][Full Text] [Related]
6. Activation of nuclear TR3 (NR4A1) by a diindolylmethane analog induces apoptosis and proapoptotic genes in pancreatic cancer cells and tumors. Yoon K; Lee SO; Cho SD; Kim K; Khan S; Safe S Carcinogenesis; 2011 Jun; 32(6):836-42. PubMed ID: 21362629 [TBL] [Abstract][Full Text] [Related]
7. NR4A1 Antagonists Inhibit β1-Integrin-Dependent Breast Cancer Cell Migration. Hedrick E; Lee SO; Doddapaneni R; Singh M; Safe S Mol Cell Biol; 2016 May; 36(9):1383-94. PubMed ID: 26929200 [TBL] [Abstract][Full Text] [Related]
8. Bis-Indole-Derived Nuclear Receptor 4A1 (NR4A1, Nur77) Ligands as Inhibitors of Endometriosis. Mohankumar K; Li X; Sung N; Cho YJ; Han SJ; Safe S Endocrinology; 2020 Apr; 161(4):. PubMed ID: 32099996 [TBL] [Abstract][Full Text] [Related]
9. Nuclear receptor 4A1 as a drug target for breast cancer chemotherapy. Hedrick E; Lee SO; Doddapaneni R; Singh M; Safe S Endocr Relat Cancer; 2015 Oct; 22(5):831-40. PubMed ID: 26229035 [TBL] [Abstract][Full Text] [Related]
10. The orphan nuclear receptor NR4A1 (Nur77) regulates oxidative and endoplasmic reticulum stress in pancreatic cancer cells. Lee SO; Jin UH; Kang JH; Kim SB; Guthrie AS; Sreevalsan S; Lee JS; Safe S Mol Cancer Res; 2014 Apr; 12(4):527-538. PubMed ID: 24515801 [TBL] [Abstract][Full Text] [Related]
11. Inactivation of the orphan nuclear receptor TR3/Nur77 inhibits pancreatic cancer cell and tumor growth. Lee SO; Abdelrahim M; Yoon K; Chintharlapalli S; Papineni S; Kim K; Wang H; Safe S Cancer Res; 2010 Sep; 70(17):6824-36. PubMed ID: 20660371 [TBL] [Abstract][Full Text] [Related]
12. Nuclear Receptor 4A1 (NR4A1) as a Drug Target for Renal Cell Adenocarcinoma. Hedrick E; Lee SO; Kim G; Abdelrahim M; Jin UH; Safe S; Abudayyeh A PLoS One; 2015; 10(6):e0128308. PubMed ID: 26035713 [TBL] [Abstract][Full Text] [Related]
13. Bis-Indole-Derived NR4A1 Ligands and Metformin Exhibit NR4A1-Dependent Glucose Metabolism and Uptake in C2C12 Cells. Mohankumar K; Lee J; Wu CS; Sun Y; Safe S Endocrinology; 2018 May; 159(5):1950-1963. PubMed ID: 29635345 [TBL] [Abstract][Full Text] [Related]
14. Activation of nerve growth factor-induced B alpha by methylene-substituted diindolylmethanes in bladder cancer cells induces apoptosis and inhibits tumor growth. Cho SD; Lee SO; Chintharlapalli S; Abdelrahim M; Khan S; Yoon K; Kamat AM; Safe S Mol Pharmacol; 2010 Mar; 77(3):396-404. PubMed ID: 20023005 [TBL] [Abstract][Full Text] [Related]
15. The nuclear receptor TR3 regulates mTORC1 signaling in lung cancer cells expressing wild-type p53. Lee SO; Andey T; Jin UH; Kim K; Singh M; Safe S Oncogene; 2012 Jul; 31(27):3265-76. PubMed ID: 22081070 [TBL] [Abstract][Full Text] [Related]
16. Nuclear receptor 4A1 (NR4A1) antagonists induce ROS-dependent inhibition of mTOR signaling in endometrial cancer. Mohankumar K; Li X; Sridharan S; Karki K; Safe S Gynecol Oncol; 2019 Jul; 154(1):218-227. PubMed ID: 31053403 [TBL] [Abstract][Full Text] [Related]
17. New Drug Candidate Targeting the 4A1 Orphan Nuclear Receptor for Medullary Thyroid Cancer Therapy. Zhang L; Liu W; Wang Q; Li Q; Wang H; Wang J; Teng T; Chen M; Ji A; Li Y Molecules; 2018 Mar; 23(3):. PubMed ID: 29498706 [TBL] [Abstract][Full Text] [Related]
18. Bis-Indole Derivatives as Dual Nuclear Receptor 4A1 (NR4A1) and NR4A2 Ligands. Upadhyay S; Hailemariam AE; Mariyam F; Hafiz Z; Martin G; Kothari J; Farkas E; Sivaram G; Bell L; Tjalkens R; Safe S Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540704 [TBL] [Abstract][Full Text] [Related]
19. 1,1-bis(3'-indolyl)-1-(p-methoxyphenyl)methane activates Nur77-independent proapoptotic responses in colon cancer cells. Cho SD; Lei P; Abdelrahim M; Yoon K; Liu S; Guo J; Papineni S; Chintharlapalli S; Safe S Mol Carcinog; 2008 Apr; 47(4):252-63. PubMed ID: 17957723 [TBL] [Abstract][Full Text] [Related]
20. TGFβ-Induced Lung Cancer Cell Migration Is NR4A1-Dependent. Hedrick E; Mohankumar K; Safe S Mol Cancer Res; 2018 Dec; 16(12):1991-2002. PubMed ID: 30072581 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]